42F-31140-84348 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-05
Registered in v-safe
2021-01-05
Dose 1 — Pfizer-BioNTech
2021-01-05
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Chills, Headache, Joint pains, Fatigue or tiredness

Adult check-in
2022-01-05
Survey response — 12 months, dose 1
MedDRA: Chest pain, Cough, Headache — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Cough, chest pain, headache

MedDRA releases: 2024-11 · check-in free text available
2022-01-05
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-06
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-05	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-01-05	Unsuccessful

Free text

Release 10 — 12 months, dose 1

2022-01-05

Symptoms: Cough, chest pain, headache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Chest pain	·	·	✓
SD	Cough	·	·	✓
SD	Headache	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release